Compare CRNX & MWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNX | MWA |
|---|---|---|
| Founded | 2008 | 1857 |
| Country | United States | United States |
| Employees | N/A | 3500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.9B |
| IPO Year | 2018 | 2006 |
| Metric | CRNX | MWA |
|---|---|---|
| Price | $83.99 | $26.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $76.75 | $30.50 |
| AVG Volume (30 Days) | ★ 6.8M | 1.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.01% |
| EPS Growth | N/A | ★ 64.86 |
| EPS | N/A | ★ 0.65 |
| Revenue | $1,039,000.00 | ★ $1,429,700,000.00 |
| Revenue This Year | $720.10 | $4.78 |
| Revenue Next Year | $184.67 | $4.27 |
| P/E Ratio | ★ N/A | $39.68 |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $25.83 | $22.74 |
| 52 Week High | $84.00 | $31.00 |
| Indicator | CRNX | MWA |
|---|---|---|
| Relative Strength Index (RSI) | 90.37 | N/A |
| Support Level | $43.40 | N/A |
| Resistance Level | $84.00 | N/A |
| Average True Range (ATR) | 0.19 | 0.00 |
| MACD | -1.64 | 0.00 |
| Stochastic Oscillator | 71.70 | 0.00 |
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments: Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.